Figure 4.Effects of DMC-HA on the Akt and Erk signalling in glioma cells. (A) Western blot analysis was conducted to assess the expression of p-Akt and p-mTor following combined treatment with TGF-β1 and DMC-HA. (B) Western blot analysis was conducted to assess the expression of N-cadherin and ZO-1 following combined treatment with TGF-β1 and LY294002. (C) Western blot analysis was conducted to assess the expression of p-Erk1/2 following combined treatment with TGF-β1 and DMC-HA. (D) Western blot analysis was conducted to assess the expression of N-cadherin and ZO-1 following combined treatment with TGF-β1 and SCH 772984.
